PRG
PROG Holdings, Inc.
PRG has slightly lower modeled downside risk, despite its lower overall score.
VRT
Vertiv Holdings Co
VRT has the edge over PRG overall, supported by stronger valuation and stronger fundamentals.
PRG Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| Healthy | |
| Stable |
PRG's revenue and cash flow are currently healthy, and its profitability and balance sheet are stable.
VRT Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
VRT's revenue, profitability, cash flow and balance sheet are all currently strong.
PRG PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 7.3x | $37.67 | — |
| Cheap | 7.4x | $27.47 | -27% |
| Fair | 10x | $38.50 | +2.2% |
| Current | 10x | $37.67 | — |
| Expensive | 14x | $50.84 | +35% |
Historical ranges are pointers, not guarantees.
PRG's PE is in its fair range at 10x. If earnings grow as analysts expect, today's price would be 7.3x next year's earnings, in its cheap range.
VRT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 23x | $210 | — |
| Current | 39x | $210 | — |
| Cheap | 58x | $308 | +47% |
| Fair | 72x | $383 | +83% |
| Expensive | 88x | $472 | +125% |
Historical ranges are pointers, not guarantees.
VRT has the edge over PRG in the historical PE scenario, which offers more potential upside but is not a forecast.
PRG Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for PRG, with profitability improving. However, they disagree widely on these estimates.
VRT Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Moderate | |
| Moderate |
Analysts expect strong earnings and revenue growth for VRT, with profitability improving.
PRG Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $5.15 | +39% |
| Q3 2026 | $3.70 | -5.9% |
| Q2 2026 | $3.61 | -29% |
| Q1 2026 | $3.65 | -25% |
| Q4 2025 | $3.59 | -21% |
| Q3 2025 | $3.93 | +8.3% |
| Q2 2025 | $5.05 | +106% |
| Q1 2025 | $4.87 | +97% |
| Q4 2024 | $4.53 | +52% |
PRG's earnings per share have fallen from their peak: $3.70 over the past year, against $5.05 in mid-2025.
VRT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.14 | +71% |
| Q3 2026 | $5.35 | +102% |
| Q2 2026 | $4.42 | +111% |
| Q1 2026 | $3.98 | +131% |
| Q4 2025 | $3.41 | +166% |
| Q3 2025 | $2.65 | +75% |
| Q2 2025 | $2.09 | +62% |
| Q1 2025 | $1.72 | +64% |
| Q4 2024 | $1.28 | +7.6% |
VRT has the edge over PRG on earnings, with more consistent year-over-year improvement.
PRG Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $725.8M | +22% |
| Q2 2026 | $719.7M | +19% |
| Q1 2026 | $742.7M | +8.6% |
| Q4 2025 | $525.4M | -16% |
| Q3 2025 | $595.1M | -1.8% |
| Q2 2025 | $604.7M | +2.1% |
| Q1 2025 | $684.1M | +6.6% |
| Q4 2024 | $623.3M | +8% |
PRG's revenue is recovering but still below its 2020 peak: $726M last quarter, up 22% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 9.1% | +0.1 points |
| Q2 2026 | 9.1% | -0.9 points |
| Q1 2026 | 8.8% | +0.6 points |
| Q4 2025 | 6.9% | -1.2 points |
| Q3 2025 | 9% | +0.9 points |
| Q2 2025 | 10% | +0.6 points |
| Q1 2025 | 8.2% | +2 points |
| Q4 2024 | 8.1% | +1.9 points |
PRG's operating margin was 9.1% last quarter, about level with the same quarter a year ago.
VRT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $4.3B | +61% |
| Q2 2026 | $3.3B | +24% |
| Q1 2026 | $2.6B | +30% |
| Q4 2025 | $2.9B | +23% |
| Q3 2025 | $2.7B | +29% |
| Q2 2025 | $2.6B | +35% |
| Q1 2025 | $2B | +24% |
| Q4 2024 | $2.3B | +26% |
VRT has the edge over PRG on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 23% | +3.5 points |
| Q2 2026 | 19% | +2.7 points |
| Q1 2026 | 17% | +2.3 points |
| Q4 2025 | 20% | +0.7 points |
| Q3 2025 | 19% | +1.4 points |
| Q2 2025 | 17% | -0.4 points |
| Q1 2025 | 14% | +1.9 points |
| Q4 2024 | 19% | +4.2 points |
VRT has the edge over PRG on profitability, with a higher operating margin.
PRG Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $103.4M | -2.9% |
| Q2 2026 | $101.2M | +49% |
| Q1 2026 | $168.6M | -19% |
| Q4 2025 | -$57.5M | +$29.3M |
| Q3 2025 | $106.5M | +257% |
| Q2 2025 | $68M | +27% |
| Q1 2025 | $208M | +56% |
| Q4 2024 | -$86.8M | +$4.2M |
PRG generated $316M in free cash flow over the past year, up 6.8% from the year before.
VRT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $654.9M | +41% |
| Q2 2026 | $926.5M | +233% |
| Q1 2026 | $654.2M | +145% |
| Q4 2025 | $885.6M | +143% |
| Q3 2025 | $463.5M | +36% |
| Q2 2025 | $277.9M | -19% |
| Q1 2025 | $266.8M | +162% |
| Q4 2024 | $364.5M | +18% |
VRT has the edge over PRG on cash flow, with more consistent year-over-year improvement.
PRG Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 2.8x | Moderate |
| Q2 2026 | 3.1x | Elevated |
| Q1 2026 | 3.5x | Elevated |
| Q4 2025 | 1.2x | Healthy |
| Q2 2020 | 1.1x | Healthy |
| Q1 2020 | 0.6x | Very low |
| Q4 2019 | 0.9x | Very low |
PRG's net debt is about 2.8 years of its operating earnings (EBITDA), up from 1.1 years a year ago.
VRT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.2x | Net Cash |
| Q2 2026 | 0.1x | Very low |
| Q1 2026 | 0.3x | Very low |
| Q4 2025 | 0.6x | Very low |
| Q3 2025 | 0.8x | Very low |
| Q2 2025 | 0.7x | Very low |
| Q1 2025 | 0.8x | Very low |
| Q4 2024 | 1.0x | Healthy |
VRT has the edge over PRG on leverage, with a lower net debt burden relative to earnings.
PRG Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 53.5 | Neutral |
| Stochastic | 57.6 | Neutral |
PRG's weekly RSI is 54 (neutral) and its Stochastic is 58 (neutral).
VRT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 43.0 | Neutral |
| Stochastic | 26.4 | Neutral |
VRT's weekly RSI is 43 (neutral) and its Stochastic is 26 (neutral).
PRG PE vs Industrials Sector
| Metric | PRG | Sector median | Relative |
|---|---|---|---|
| PE | 10x | 24x | 58% below |
| PE % | 47 | 58 | 11 pts below |
PRG has the edge over VRT on valuation relative to its sector.
VRT PE vs Industrials Sector
| Metric | VRT | Sector median | Relative |
|---|---|---|---|
| PE | 39x | 24x | 63% above |
| PE % | 3 | 58 | 55 pts below |
VRT is trading at 39x earnings, a 63% premium to the Industrials sector's median of 24x.
PRG Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $33.2 | 13% above |
| 20 week MA | $38.2 | 1.3% below |
| 50 week MA | $35.2 | 7% above |
| 100 week MA | $33.6 | 12% above |
| 200 week MA | $33.8 | 11% above |
PRG has the edge over VRT on trend strength, trading above more of its moving averages.
VRT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $221.8 | 5.5% below |
| 20 week MA | $254.4 | 18% below |
| 50 week MA | $253.9 | 17% below |
| 100 week MA | $189.1 | 11% above |
| 200 week MA | $123.5 | 70% above |
VRT has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 70% above its 200-week average.
PRG Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $56.3 | $54.0 | -4.1% |
| 2021 | $54.0 | $45.0 | -17% |
| 2022 | $45.0 | $17.2 | -62% |
| 2023 | $17.2 | $30.9 | +80% |
| 2024 | $30.9 | $42.2 | +36% |
| 2025 | $42.2 | $30.5 | -28% |
| 2026 YTD | $30.5 | $37.7 | +24% |
PRG has finished lower in four of the last six years. It's up 24% so far in 2026.
VRT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $10.9 | $18.9 | +73% |
| 2021 | $18.9 | $24.9 | +31% |
| 2022 | $24.9 | $12.8 | -48% |
| 2023 | $12.8 | $48.0 | +275% |
| 2024 | $48.0 | $115.1 | +140% |
| 2025 | $115.1 | $167.6 | +46% |
| 2026 YTD | $167.6 | $209.6 | +25% |
VRT has the edge over PRG on returns for 2026, with the stronger performance.